The FDA is removing any mention of risks related to breast cancer, heart disease, and dementia on hormone therapy products ...
Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...
New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel antibiotic candidate sorfequiline (TBAJ-876), a next-generation diarylquinoline, ...
Statista on MSN
Drug-Resistant TB Slows Path to Global 90% Target
This chart shows the share of people diagnosed with tuberculosis (TB) who were cured/completed their treatment, by TB type (in %)*.
My primary care doctor has prescribed the medication Evenity for my osteoporosis. I have been on Fosamax for about three years, but my recent bone density scan ...
The recently released Global TB Report 2025 shows that although the burden of tuberculosis in India continues to decline, the ...
Experts today sounded an alarm over the death toll as millions more are in line to get the jabs to curb the nation's bulging ...
We show that, compared with surgeon predictions and existing risk-prediction tools, our machine-learning model can enhance ...
The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...
COMMUNITY health worker Pauline Kove has been on the frontline for 20 years and is based at a World Vision-supported TB clinic at Six Mile in Port Moresby.
A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback